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Dearterialization of the liver causes intrahepatic cholestasis due
to reduced bile transporter expression
Abstract
BACKGROUND: Bile duct injury after hepatic artery thrombosis (HAT) in liver transplantation is
believed to be caused by ischemia predominantly. We aimed to define the involvement of bile secretory
dysfunction in the pathogenesis of liver injury after HAT. METHODS: In a murine model, the main
hepatic artery, the extrahepatic peribiliary plexus, or both arterial connections to the liver were
interrupted (n=5 for each group). After 1, 14, or 28 days, hepatobiliary function was assessed by
analysis of bile transporter expression, serum bile acids and bilirubin, and hepatic ATP content. In
addition, cellular injury was assessed by light microscopy and biochemical markers. RESULTS: There
were no signs of hepatobiliary dysfunction or injury in sham-operated animals or in mice with
interruption of the hepatic artery or the extrahepatic peribiliary plexus alone. However, as early as 24 hr
after complete dearterialization, bile transporter expression was significantly reduced and intrahepatic
cholestasis started to progress the following weeks. Histologic studies at 28 days after complete
dearterialization showed severe hepatobiliary injury. CONCLUSIONS: This study indicates that arterial
blood supply is critical for normal bile secretion. Bile duct injury after complete arterial deprivation is
preceded by a loss of bile secretory function and subsequent intrahepatic cholestasis.
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Abstract  
 
Background Bile duct injury after hepatic artery thrombosis (HAT) in liver transplantation is 
believed to be caused by ischemia predominantly. We aimed to define the involvement of 
bile secretory dysfunction in the pathogenesis of liver injury after HAT. Methods In a murine 
model, the main hepatic artery, the extrahepatic peribiliary plexus or both arterial connections 
to the liver were interrupted (n=5 for each group). After 1, 14 or 28 days, hepatobiliary 
function was assessed by analysis of bile transporter expression, serum bile acids and 
bilirubin, and hepatic ATP-content. In addition, cellular injury was assessed by light 
microscopy and biochemical markers. Results There were no signs of hepatobiliary 
dysfunction or injury in sham-operated animals or in mice with interruption of the hepatic 
artery or the extrahepatic peribiliary plexus alone. However, as early as 24 hours after 
complete dearterialization, bile transporter expression was significantly reduced and 
intrahepatic cholestasis started to progress the following weeks. Histological studies at 28 
days after complete dearterialization showed severe hepatobiliary injury. Conclusions This 
study indicates that arterial blood supply is critical for normal bile secretion. Bile duct injury 
after complete arterial deprivation is preceded by a loss of bile secretory function and 
subsequent intrahepatic cholestasis.  
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Introduction 
Hepatic artery thrombosis (HAT) after human orthotopic liver transplantation (OLT) is 
a devastating complication. HAT, the most common complication after liver transplantation, 
occurs in about 3 to 9% of adults and children and is associated with high morbidity and 
mortality (1). Outside the setting of transplantation, HAT appears to have limited 
consequences for the liver. For example in the treatment of multiple hepatic metastases, 
occlusion of the hepatic artery is well tolerated. This can largely be explained by the 
presence and rapid development of arterial collaterals, replacing the occluded artery (2, 3). In 
this scenario, perfusion is maintained by portal venous and hepatic arterial input. The 
transplanted liver, however, differs from the native livers in that arterial blood supply from 
accessory arteries and collateralization is completely interrupted during hepatectomy. As a 
consequence of HAT, the transplanted liver is perfused by the portal vein alone.  
Arterial blood supply is closely associated with biliary structures before entering the 
sinusoids. Arterial blood is supplied to the bile ducts through a network of arterioles and 
capillaries, called the peribiliary plexus (PBP), coming from the hepatic arteries (4). Due to 
this distribution and its greater oxygen content, complete loss of arterial blood supply to the 
liver is generally followed by severe morbidity, mainly from biliary damage. This condition is 
often referred to as ischemic cholangiopathy.  
Of interest, hepatic artery blood flow seems to be critical for the recovery of bile 
secretory function after OLT (5). Ex vivo completely dearterialized porcine livers and 
perfused by the portal vein alone, showed diminished choleresis carried on phospholipids 
(6). In human, phospholipids are secreted into bile via the concerted action of the multidrug 
resistance 3 MDR3 P-glycoprotein (gene symbol ABCB4), located in the canalicular 
membrane of hepatocytes (7). Recently, we demonstrated in mice heterozygous for the 
disruption of the Mdr2 gene (a homologue of human MDR3), that endogenous bile salts act 
cytotoxic after OLT, due to intrahepatic cholestasis and intracellular bile salt retention (8). 
Intrahepatic cholestasis originates from altered bile transporter expression/function and 
altered secretory responses induced by proinflammatory cytokines (9). 
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This introduces the possibility that the observed hepatobiliary injury can be attributed 
in part to the inability to maintain bile secretion. When the graft looses arterial blood supply, 
metabolic capacity of hepatocytes may be limited. Hepatocellular damage may in turn induce 
pro-inflammatory cytokines TNF-alpha and IL1-beta. However, direct evidence for such 
cholestatic injury is still lacking. To confirm the critical involvement of bile secretory function 
in the pathogenesis of hepatobiliary injury, arterial perfusion by the hepatic artery or 
extrahepatic PBP alone was compared to complete dearterialization of the liver in a mouse 
model. Hepatobiliary injury and hepatocyte transporter expression, responsible for sinusoidal 
uptake (Ntcp) and canalicular secretion of bile salts (Bsep) and phospholipids (Mdr2) were 
assessed after one, fourteen and twenty eight days. In this study, evidence is provided for a 
pivotal role of endogenous bile salts in the pathogenesis of hepatocellular injury after loss of 
arterial blood supply. 
  
 
Materials and methods 
Animals 
In this study FVB/N mice (25–30 g) were used (n=5 for each group) and obtained from 
Harlan (Zeist, The Netherlands). Mice were housed in a light- and temperature-controlled 
facility. Food and water were available ad libitum. Mice were maintained on standard 
laboratory chow (Provimi Kliba AG, Kaiseraugst, Switzerland). Animals received human care 
according to guidelines of the University Hospital of Zurich. The Cantonal Veterinary Office of 
Zurich approved the study protocol. 
 
Surgical procedures 
A murine model of hepatic arterial deprivation was used. Livers were disconnected 
from the main hepatic artery, the extrahepatic PBP or both. In sham operated animals no 
additional vascular intervention was performed. In summary: after midline laparotomy, all 
oesophageal collateral vessels and ligaments to the liver were dissected. The main hepatic 
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artery was ligated using a double suture just above the level of the bifurcation of the 
gastroduodenal and celiac artery. Ligation of the extrahepatic PBP was established by 
transsection of the extrahepatic bile duct. The reconnection of the bile duct was subsequently 
established by using a polyethylene stent (inner diameter 0.28 mm, outer diameter 0.61 mm; 
SIMS Portex, Kent, UK), which was secured with two circular ties.  
After 1, 14 and 28 days respectively, the animals (n=5, for each time point, per group) 
underwent relaparotomy. Blood was collected from the inferior vena cava and the liver was 
rapidly excised and processed for further analysis. All serum samples were snap-frozen and 
stored at -80 oC. 
For determination of baseline values, a separate group of mice (n=5) was used to 
obtain samples of serum and liver tissue.  
 
Analysis of Serum 
Serum aspartate aminotransferase (AST), alkaline phosphatase (ALP), and total 
bilirubin levels were measured using the Ektachem DT60 II System and DTSC II Module 
(Johnson & Johnson Clinical Diagnostics Inc., Rochester, NY). Serum total bile salt 
concentrations were measured spectrophotometrically using 3α-hydroxysteroid 
dehydrogenase (10). 
 
Histology and Immunohistochemistry 
Liver tissues were immersion-fixed in 4% PBS-buffered formalin, embedded in 
paraffin, sectioned, and stained with haematoxylin-eosin and sirius red using standard 
histological techniques. In addition, slides were immunostained for cytokeratin (polyclonal 
rabbit antibody; DakoCytomation) and Ki-67 (monoclonal rabbit clone SP6; NeoMarkers) 
using the Ventana Discovery automated staining system with an iView DAB kit (Ventana, 
Tucson, AZ). All histological assessments were performed by a single pathologist (W.J.) who 
was unaware of other study data. 
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Real-time Quantitative PCR 
Total RNA was extracted from 50 mg of liver tissue using TRIzol reagent (Invitrogen, 
Paisley, UK) and 5 µg of RNA was reverse transcribed using ThermoScript RT-PCR System 
(Invitrogen). Quantitative real-time polymerase chain reaction amplification and data analysis 
were performed using an ABI Prism 7000 Sequence Detector System (PE Applied 
Biosystems, Rotkreuz, Switzerland). TaqMan gene expression assay (PE Applied 
Biosystems) for Ntcp, Bsep, Mdr2, TNF-alpha (assay ID Mm00443258_m1) and IL1-beta 
(assay ID Mm00434228_m1) were used to quantify mRNA expression after normalisation to 
the house-keeping gene 18S (TaqMan ribosomal RNA control reagents, PE Applied 
Biosystems) (8). The results shown represent percentage induction in sham operated 
animals, and livers that were perfused by either the hepatic artery or extrahepatic PBP and 
complete dearterialized livers, compared to baseline levels. 
 
Membrane Isolation and Western blotting 
Total liver membrane fractions were prepared according to Trauner et al. (11), with a 
minor modification (single 39,000 RPM centrifugation step of gauze filtered liver 
homogenates). Membrane fractions were re-suspended in 300 mM Sucrose, 10 mM HEPES 
at pH 7.5, and snap-frozen in liquid nitrogen. Protein concentrations were determined with 
the bicinchoninic acid method (Pierce, Rockford, IL) (12).  
Total liver membranes (40 µg) were separated using a 7.5% sodium dodecyl sulfate 
(SDS) polyacrylamide gel electrophoresis, and transferred to nitrocellulose. The blots were 
probed with rabbit antisera raised against Ntcp (13) and Bsep (14) at appropriate dilutions. 
Immune detection was assessed by using the ECL chemiluminescent detection system 
(Amersham, UK). For quantitative analysis of expression levels, autoradiographs were 
scanned with an AlphaImagerTM 1220 gel documentation system (Witec AG, Luzern, 
Switzerland). 
 
ATP extraction and measurement 
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Liver samples were immediately frozen in liquid nitrogen until the extraction procedure. The 
frozen tissue was powdered and homogenized in 1 mL of 0.6 N ice-cold HCLO4 and 
incubated for 10 minutes. The precipitated proteins were removed by centrifugation (10,000 x 
g for 10 minutes), and 300 µL of supernatant was neutralized by 1 N KHCO3. Forty 
microliters of supernatant were pipetted into the wells of a white non-phosphorescent 
microplate, placed in a luminometer (Labsystems Luminoscan 1.2-0), and processed by 
addition of 150 µL of ATP monitoring reagent. ATP concentrations were calculated from a 
calibration curve constructed at the same time by means of standard ATP dissolved in the 
appropriate solution for each experiment. 
 
Statistics 
Values are expressed as mean ± SD. Data was analyzed using SPSS software 
version 11.5 for Windows (SPSS Inc., Chicago, Il). A non-paired Mann-Whitney U-test and 
analysis of variance (ANOVA) were used for the comparison between the groups, 
respectively. Differences were considered statistically significant when p was ≤ 0.05. 
 
 
Results 
Complete arterial deprivation of the liver in mice. 
The arterial anatomy was carefully evaluated in every animal. In none of the animals 
collateral vessels were observed between the gastroduodenal artery and extrahepatic PBP. 
The main hepatic artery normally arises from the celiac artery. Retrospectively during 
harvesting, in rare cases an adjuvant hepatic artery was patent, arising from the main hepatic 
artery or left gastric artery, supplying the right and left hemi-liver, respectively. These animals 
(n=5, 3.5% of all operated animals) were excluded from the experiment.  
Patency of the arterial ligation was checked in all mice that underwent ligation, either 
from the main hepatic artery, extrahepatic PBP or both connections, by transsection of the 
arteries. No animal was found to have an open artery, when this was meant to be. 
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To exclude the possibility that obstruction of the biliary stent anastomosis contributed 
to the cholestatic changes, all animals that underwent relaparotomy, patency of the main bile 
duct was checked. Ligation of extrahepatic PBP using a stent anastomosis was not 
associated with an increased risk of bile duct occlusion compared with sham-operated 
animals.  
There were no technical complications. 
  
Does hepatic arterial deprivation have an impact on animal survival? 
All animals that underwent an interruption of the arterial blood flow from either the 
hepatic artery or extrahepatic PBP, and maintained arterial perfusion survived 28 days. Two 
out of five animals that underwent complete dearterialization of the liver, died between 21 
and 28 days after surgery.  
 
Does hepatic arterial deprivation induce hepatocyte injury and cholestasis? 
Biochemical analysis included both serum and bile measurements. Serum AST levels 
were used as markers of hepatocyte injury. Serum levels of ALP, total bile salts and bilirubin 
served as markers of cholestasis. There were no significant differences in serum AST, ALP, 
total bilirubin, and bile salts between sham operated animals, and livers that were perfused 
by either the hepatic artery or extrahepatic PBP. However, in animals with complete 
dearterialized livers, serum AST, ALP, total bilirubin and total bile salts were increased 
significantly (fig.1). 
 
Does arterial deprivation lead to liver damage? 
Histological analysis of liver parenchyma and large bile ducts was performed after 
sham operation, ligation of the extrahepatic PBP, the hepatic artery, or both. No 
morphological abnormalities were observed in the portal tracts and lobular parenchyma after 
sham operation, ligation of the hepatic artery or extrahepatic PBP at 1, 14 and 28 days after 
surgery (fig.2A-D; data not shown). In contrast, ligation of both hepatic artery and 
 10
extrahepatic PBP was associated with portal inflammation and ductular reaction at14 and 28 
days after surgery (fig.2A,B). Lobular parenchyma was maintained in most of these livers, 
but areas of ischemic necrosis and bile infarcts were present in the liver parenchyma of 
some of these mice (fig.2C). Ki-67 staining of complete dearterialized livers revealed 
increased hepatocyte proliferation at 14 and 28 days after surgery in comparison to livers 
after sham operation, ligation of the hepatic artery or extrahepatic PBP, suggesting increased 
hepatocyte turnover (fig.2D). After 28 days, large bile ducts showed purulent cholangitis in 
mice with ligation of both hepatic artery and extrahepatic PBP (fig.2E).  
 
Does arterial deprivation change expression of key hepatocyte transporters?  
To evaluate the molecular mechanisms underlying the observed cholestatic 
phenotype, we measured the expression of hepatocellular transporters responsible for 
sinusoidal uptake (Ntcp) and canalicular secretion of bile salts (Bsep) and phospholipids 
(Mdr2). There were no significant differences in Ntcp, Bsep and Mdr2 mRNA levels between 
sham operated animals, and livers that were perfused by either the hepatic artery or 
extrahepatic PBP alone. However, Ntcp mRNA levels were significantly reduced in 
completely dearterialized livers at all time points. Bsep mRNA levels showed a tendency to 
increase at day 14, however, this did not reach significance, whereas Mdr2 mRNA levels 
were significantly increased at day 14 (fig.3). In contrast, Ntcp and Bsep protein levels were 
significantly reduced in completely dearterialized livers at all time points (fig.4).   
 
Is reduced bile secretory function associated with ATP depletion? 
To investigate whether a reduced energy state of the hepatic tissue, might be 
responsible for the decrease of (ATP-dependent) hepatocyte transporter synthesis, ATP 
levels were measured in liver tissue at day 1, 14 and 28. There were no significant 
differences in ATP levels between sham operated animals, and livers that were perfused by 
either the hepatic artery or extrahepatic PBP alone at day 1 and 14. Completely 
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dearterialized livers, however, had significantly lower ATP levels at 24 hours which were 
restored after 14 days (fig.5).  
 
Can intrahepatic cholestasis maintained by induced proinflammatory cytokines? 
To study whether intrahepatic cholestasis was associated with the induction of pro-
inflammatory cytokines that may aggravate the injury, TNF-alpha and IL1-beta mRNA levels 
were determined. 
There were no significant differences in mRNA levels for TNF-alpha and IL1-beta 
between sham operated animals and livers that were perfused by either the hepatic artery or 
peribiliary plexus alone, at all time points. Complete dearterialized livers, however, showed 
significant induction of TNF-alpha and IL1-beta mRNA levels reaching significance at 14 and 
28 days, respectively (fig.6). 
  
 
Discussion 
Our aim was to investigate the consequences of arterial deprivation in the mouse 
liver. Impaired arterial perfusion induced by ligation of either the hepatic artery or the 
extrahepatic PBP alone did not induce marked histological, biochemical or molecular 
changes in the liver. This suggests that both the hepatic artery and the extrahepatic PBP 
have the capacity to complement for each other. However, complete loss of arterial blood 
supply to the liver resulted in hepatobiliary injury, with two out five animals dying between 21 
and 28 days after surgery. These results are in contrast to those of Beaussier et al., who 
showed that completely dearterialized rat livers recover from ischemia-induced liver damage 
within six weeks (2), and in contrast to  the situation after non-arterialized OLT in rats, in 
which omission of the hepatic artery is not associated with significant negative effects and 
poor outcome of the procedure (15-17).  However, our results are consistent with the 
previous observation that arterialized mouse OLT  is associated with less liver injury and 
better survival in comparison to OLT without rearterialization (18). Taken together, these 
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findings suggest that the mouse model, rather than the rat model, resembles more closely 
the consequences of hepatic blood supply after human OLT.   
Complete arterial deprivation in mice may serve as a model to study the pathogenesis 
of graft damage after HAT in human OLT. Wheatley et al. have indicated that hepatic arterial 
blood flow is critical for the recovery of hepatocyte bile secretory function after OLT (5). In the 
absence of bile secretion, bile salts can accumulate and act cytotoxic (8). This introduces the 
possibility that the observed hepatobiliary injury can be attributed, in part, to decreased bile 
secretory function of hepatocytes after the graft looses arterial blood supply. However, formal 
evidence for such cholestatic injury after loss of arterial blood supply is lacking. Therefore, 
we analyzed the effects of complete loss of hepatic arterial blood flow on liver histology, 
serum parameters of cholestasis and the expression of hepatocyte transporters. The effects 
were compared to those after ligation of either the hepatic artery or the extrahepatic PBP 
alone. 
Protein expression of the bile salt transporters Ntcp and Bsep was decreased 
significantly in completely dearterialized livers. As a consequence, the serum conjugated bile 
salt levels increased. The basolateral bile salt transporter Ntcp was down-regulated rapidly 
on both mRNA and protein levels in complete dearterialized livers. In general, changes in 
basolateral bile salt transporter (Ntcp) expression have been interpreted largely as 
secondary and adaptive phenomena, in an attempt to protect the hepatocyte from bile acid 
overload under cholestatic conditions (19). In parallel, Bsep levels were also decreased 
rapidly in complete dearterialized livers. Conversely, Bsep and Mdr2 transcript levels were 2-
fold up-regulated in complete dearterialized livers at day 14. Up-regulation of canalicular 
transport systems is known to be an initial response of cholestatic hepatocytes. It is 
presumed to be a mechanism to overcome bile salt overload and diminish the extent of liver 
injury produced by bile salt retention (20-22).  
Our results suggest that endogenous bile salts may actively contribute to liver injury 
after loss of arterial blood supply of the liver graft after OLT. In our hypothesis, the putative 
insult to the liver is an interaction between ischemic bile duct injury and retention of 
 13
endogenous bile salts. Although the bile duct is affected by ischemia predominantly, 
hepatocellular injury is an invariable feature of cholestasis, associated with accumulation of 
bile salts in the liver and blood (23). As a consequence of early limited metabolic capacity of 
hepatocytes (ATP depletion) bile transporter expression and function are reduced. 
Subsequently, bile salts and other bile compounds accumulate, as indicated by increased 
serum alkaline phosphatase levels, total bilirubin and bile salt levels increase and the 
animals become cholestatic. Bile salt retention in the liver causes hepatocellular injury and 
hepatocyte proliferation, perpetuates the initial inflammatory response, leading to chronic 
portal inflammation and ductular proliferation (24, 25). At the same time, increased pro-
inflammatory mediators (TNF-alpha and IL1-beta) maintain the altered secretory responses 
(9).  
HAT after OLT has been shown to result in ischemic injury of the bile ducts (26, 27).  
We can not exclude that some of the changes observed in the liver parenchyma after 
complete arterial deprivation in mice are due to ischemic damage of large bile ducts. 
Consistent with this notion, we observed purulent cholangitis of large bile ducts 28 days after 
complete arterial deprivation. This inflammation may induce some obstruction of large bile 
ducts with secondary impaired bile flow. This possibility is supported by the observation that 
(prolonged) decreased hepatic Ntcp and Bsep protein levels have also been observed in 
human cholestatic liver diseases (28). 
Therapeutic strategies should therefore focus on maintaining choleresis and awaiting 
collateralization. Ursodeoxycholic acid is known to improve cholestatic disorders. It has been 
shown to stimulate canalicular transport and bile secretion (29). However, its choleretic 
action also increases biliary pressure, which has been shown to aggravate bile infarcts and 
hepatocyte necrosis in the homozygous Mdr2-/- mice (30). Administration of fibrates or 
statins might provide an alternative therapeutic approach to modify hepatocellular injury after 
HAT (31, 32). These lipid lowering drugs have all been shown to induce biliary phospholipid 
secretion by the induction of Mdr2. However, fibrates and statins not only induce Mdr2, but 
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also lower Bsep and Ntcp expression and potentially lower bile flow  (33). Their use is also 
not without side-effects. 
In conclusion, our data indicate that arterial blood flow either by the hepatic artery or 
extrahepatic PBP is mandatory to preserve normal liver architecture and bile secretory 
function. Complete loss of arterial blood supply to the liver results in a decrease in 
hepatobiliary secretory function and subsequent intrahepatic cholestasis. Intrahepatic 
cholestasis induces hepatocellular injury and aggravates ischemic injury in the presence of 
HAT. Therapeutic strategies in patients with HAT after OLT should, therefore, not only focus 
on immediate restoration of the arterial blood supply, but also aim at maintaining choleresis 
and avoiding intrahepatic cholestasis. 
 
 
References 
1. Silva MA, Jambulingam PS, Gunson BK et al. Hepatic artery thrombosis following orthotopic liver 
transplantation: a 10-year experience from a single centre in the United Kingdom. Liver Transpl 2006;12:146-
151. 
2. Beaussier M, Wendum D, Fouassier L et al. Adaptative bile duct proliferative response in experimental 
bile duct ischemia. J Hepatol 2005;42:257-265. 
3. Itai Y, Matsui O. Blood flow and liver imaging. Radiology 1997;202:306-314. 
4. Northover JM, Terblanche J. A new look at the arterial supply of the bile duct in man and its surgical 
implications. Br J Surg 1979;66:379-384. 
5. Wheatley AM. Hepatic artery and post-transplantation hemodynamics and function. Am J Transplant 
2004;4:290; author reply 291. 
6. Foley DP, Ricciardi R, Traylor AN  et al. Effect of hepatic artery flow on bile secretory function after 
cold ischemia. Am J Transplant 2003;3:148-155. 
7. Huang L, Vore M. Multidrug resistance p-glycoprotein 2 is essential for the biliary excretion of 
indocyanine green. Drug Metab Dispos 2001;29:634-637. 
8. Hoekstra H, Porte RJ, Tian Y et al. Bile salt toxicity aggravates cold ischemic injury of bile ducts after 
liver transplantation in Mdr2+/- mice. Hepatology 2006;43:1022-1031. 
 15
9. Geier A, Dietrich CG, Voigt S et al. Effects of proinflammatory cytokines on rat organic anion 
transporters during toxic liver injury and cholestasis. Hepatology 2003;38:345-354. 
10. Turley SD, Dietschy JM. Re-evaluation of the 3 alpha-hydroxysteroid dehydrogenase assay for total 
bile acids in bile. J Lipid Res 1978;19:924-928. 
11. Trauner M, Arrese M, Soroka CJ et al. The rat canalicular conjugate export pump (Mrp2) is down-
regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997;113:255-264. 
12. Smith PK, Krohn RI, Hermanson GT et al. Measurement of protein using bicinchoninic acid. Anal 
Biochem 1985;150:76-85. 
13. Stieger B, Hagenbuch B, Landmann L, Hochli M, Schroeder A, Meier PJ. In situ localization of the 
hepatocytic Na+/Taurocholate cotransporting polypeptide in rat liver. Gastroenterology 1994;107:1781-1787. 
14. Gerloff T, Stieger B, Hagenbuch B et al. The sister of P-glycoprotein represents the canalicular bile salt 
export pump of mammalian liver. J Biol Chem 1998;273:10046-10050. 
15. Ramos E, Closa D, Hotter G, Rosello-Catafau J, Gelpi E, Fernandez-Cruz L. The impact of 
arterialization on prostanoid generation after liver transplantation in the rat. Transplantation 1994;58:140-144. 
16. Morimoto Y, Kamiike W, Nishida T et al. Improvement of rat liver graft function by insulin 
administration to donor. Gastroenterology 1996;111:1071-1080. 
17. Kamada N, Sumimoto R, Kaneda K. The value of hepatic artery reconstruction as a technique in rat 
liver transplantation. Surgery 1992;111:195-200. 
18. Tian Y, Rudiger HA, Jochum W, Clavien PA. Comparison of arterialized and nonarterialized orthotopic 
liver transplantation in mice: prowess or relevant model? Transplantation 2002;74:1242-1246. 
19. Gartung C, Schuele S, Schlosser SF, Boyer JL. Expression of the rat liver Na+/taurocholate 
cotransporter is regulated in vivo by retention of biliary constituents but not their depletion. Hepatology 
1997;25:284-290. 
20. Lee JM, Trauner M, Soroka CJ, Stieger B, Meier PJ, Boyer JL. Expression of the bile salt export pump 
is maintained after chronic cholestasis in the rat. Gastroenterology 2000;118:163-172. 
21. Trauner M, Meier PJ, Boyer JL. Molecular regulation of hepatocellular transport systems in cholestasis. 
J Hepatol 1999;31:165-178. 
22. Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. N Engl J Med 1998;339:1217-
1227. 
23. Palmeira CM, Rolo AP. Mitochondrially-mediated toxicity of bile acids. Toxicology 2004;203:1-15. 
 16
24. Schmucker DL, Ohta M, Kanai S, Sato Y, Kitani K. Hepatic injury induced by bile salts: correlation 
between biochemical and morphological events. Hepatology 1990;12:1216-1221. 
25. Lazaridis KN, Strazzabosco M, Larusso NF. The cholangiopathies: disorders of biliary epithelia. 
Gastroenterology 2004;127:1565-1577. 
26. Valente JF, Alonso MH, Weber FL, Hanto DW. Late hepatic artery thrombosis in liver allograft 
recipients is associated with intrahepatic biliary necrosis. Transplantation 1996;61:61-65. 
27. Abbasoglu O, Levy MF, Vodapally MS et al. Hepatic artery stenosis after liver transplantation--
incidence, presentation, treatment, and long term outcome. Transplantation 1997;63:250-255. 
28. Zollner G, Fickert P, Zenz R et al. Hepatobiliary transporter expression in percutaneous liver biopsies of 
patients with cholestatic liver diseases. Hepatology 2001;33:633-646. 
29. Fickert P, Zollner G, Fuchsbichler A et al. Effects of ursodeoxycholic and cholic acid feeding on 
hepatocellular transporter expression in mouse liver. Gastroenterology 2001;121:170-183. 
30. Fickert P, Zollner G, Fuchsbichler A et al. Ursodeoxycholic acid aggravates bile infarcts in bile duct-
ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology 2002;123:1238-1251. 
31. Chianale J, Vollrath V, Wielandt AM et al. Fibrates induce mdr2 gene expression and biliary 
phospholipid secretion in the mouse. Biochem J 1996;314 ( Pt 3):781-786. 
32. Hooiveld GJ, Vos TA, Scheffer GL et al. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors 
(statins) induce hepatic expression of the phospholipid translocase mdr2 in rats. Gastroenterology 1999;117:678-
687. 
33. Kok T, Bloks VW, Wolters H et al. Peroxisome proliferator-activated receptor alpha (PPARalpha)-
mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice. Biochem J 2003;369:539-
547. 
 
 
 
 
 
 
 
 
 17
Figure legends 
Figure 1 
Serum (A) aspartate aminotransferase (AST), (B) alkaline phosphatase, (C) total bilirubin 
and (D) bile salt levels. Data shown are mean +/- SD. There were no significant differences 
for AST, alkaline phosphatase, total bilirubin and bile salts between sham (▲) operated 
animals and livers that were perfused by either the hepatic artery (■) or peribiliary plexus (♦) 
alone. However, in animals with completely dearterialized livers (●) serum AST, alkaline 
phosphatase, total bilirubin and bile salts were increased significantly (* p ≤ 0.025) indicating 
liver injury and cholestasis. 
 
Figure 2 
Histological analysis of liver parenchyma 28 days after sham operation, ligation of the 
hepatic artery (HA), extrahepatic peribiliary plexus (PBP), or complete dearterialization 
(HA+PBP).  
(A) Inflammation and ductular reaction in the portal tracts after complete dearterialization 
(H&E, original magnification 200x). 
(B) Ductular reaction after dearterialization revealed by cytokeratin immunostaining (original 
magnification 200x).  
(C) Maintained lobular liver parenchyma in all experimental groups (original magnification 
200x).  
(D) Increased numbers of Ki-67 positive hepatocytes and inflammatory cells after complete 
dearterialization (original magnification 200x). 
(E) Purulent cholangitis of large bile ducts after complete dearterialization (original 
magnification 100x). 
 
Figure 3  
Transcript levels of (A) Ntcp, (B) Bsep and (C) Mdr2.  
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mRNA coding for Ntcp, Bsep and Mdr2 were quantified by RT-PCR (n=5 for each group) and 
the number of transcripts normalized to baseline. Data shown are mean +/- SD. There were 
no significant differences in mRNA levels for Ntcp, Bsep and Mdr2 between sham (▲) 
operated animals and livers that were perfused by either the hepatic artery (■) or peribiliary 
plexus (♦) alone. However, mRNA levels for Ntcp of complete dearterialized livers (●) were 
significantly (* p ≤ 0.036) reduced at all time points. In contrast to Mdr2, which was 
significantly (* p < 0.01) increased at day 14, Bsep showed a tendency to increase at day 14, 
however this did not reach significance. 
 
Figure 4 
Expression for Ntcp and Bsep. 
(A) Western blot analysis of 50 kDa Ntcp (top row) and 160 kDa Bsep (bottom row) from liver 
extracts (n=3 for each group) in control, sham and completely dearterialized (HA+PBP) 
livers, at day 1, 14 and 28. The levels were normalized to control animals and set to 100%. 
Samples shown are representative for 3 individual total liver membrane preparations. (B-C) 
No clear differences in protein expression of Ntcp and Bsep were observed between control 
and sham operated animals. However, in complete dearterialized livers Ntcp and Bsep 
expression were decreased significantly (* p ≤ 0.05).   
 
Figure 5  
Liver ATP levels. 
ATP concentrations from liver extracts (n=3 for each group) in sham and completely 
dearterialized (HA+PBP) livers, at day 1, 14 and 28. ATP levels (nMoles/mg) were significant 
(* p = 0.05) reduced in complete dearterialized livers at day 1, which might explain the early 
decline in bile salt transporter translation. ATP levels turned normal at 14 and 28 days. 
 
Figure 6  
Transcript levels of (A) TNF-alpha and (B) IL1-beta.  
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mRNA coding for TNF-alpha and IL1-beta were quantified by RT-PCR (n=5 for each group) 
and the number of transcripts normalized to baseline. Data shown are mean +/- SD. There 
were no significant differences in mRNA levels for TNF-alpha and IL1-beta between sham 
(▲) operated animals and livers that were perfused by either the hepatic artery (■) or 
peribiliary plexus (♦) alone. Completely dearterialized livers (•), however, showed significant 
(* p ≤ 0.025) induction of TNF-alpha and IL1-beta mRNA levels after 14 and 28 days, 
respectively.  






